Featured Topics
Calendar

February 25, 2026

FY/Q4 2025 Results / Annual Report
Financial News Conference for Fiscal 2025

April 24, 2026

Annual Stockholders’ Meeting 2026
Press Releases
Share Price / Index
November 19, 2025
Not intended for U.S. and UK Media
Lynkuet™ (elinzanetant) approved in the EU for the treatment of moderate to severe vasomotor symptoms associated with menopause or endocrine therapy for breast cancer
November 12, 2025
Business figures for the third quarter:
Bayer confirms 2025 Group outlook, progresses on strategic priorities
November 06, 2025
Dr. Judith Hartmann to become new Chief Financial Officer of Bayer AG

Our Products

Our broad product portfolio includes many world-famous brands that have shaped our Bayer brand. With our products, we are helping to find solutions to some of the greatest challenges of our time. So that health and nutrition can be made available to everyone.